Tag: David Coman
Science 37 to be acquired by eMed in $38m all-cash deal
Science 37 Holdings, Inc. (Nasdaq: SNCE), a leader in the clinical research industry, has announced a definitive merger agreement with eMed, LLC, a pioneer in ... Read More
Clinical research company Science 37 to go public in $1bn deal with LifeSci
Science 37, an American clinical research company, has agreed to merge with blank check company LifeSci Acquisition II in a deal that values the former ... Read More